Submit Feedback
Learn more about Johnson & Johnson's Revenue by Segment and Revenue by Region.
Check out competitors to Johnson & Johnson in a side-by-side comparison.
Explore additional financial metrics for Johnson & Johnson.
| 2015 | 70074000000.00 |
|---|---|
| 2016 | 71890000000.00 |
| 2017 | 76450000000.00 |
| 2018 | 81581000000.00 |
| 2019 | 82059000000.00 |
| 2020 | 82584000000.00 |
| 2021 | 78740000000.00 |
| 2022 | 79990000000.00 |
| 2023 | 85159000000.00 |
| 2024 | 88821000000.00 |
| 2025 | 94193000000.00 |
| Apr 2016 | 17482000000.00 |
|---|---|
| Jul 2016 | 18482000000.00 |
| Oct 2016 | 17820000000.00 |
| Dec 2016 | 18106000000.00 |
| Apr 2017 | 17766000000.00 |
| Jul 2017 | 18839000000.00 |
| Oct 2017 | 19650000000.00 |
| Dec 2017 | 20195000000.00 |
| Apr 2018 | 20009000000.00 |
| Jul 2018 | 20830000000.00 |
| Sep 2018 | 20348000000.00 |
| Dec 2018 | 20394000000.00 |
| Mar 2019 | 20021000000.00 |
| Jun 2019 | 20562000000.00 |
| Sep 2019 | 20729000000.00 |
| Dec 2019 | 20747000000.00 |
| Mar 2020 | 20691000000.00 |
| Jun 2020 | 18336000000.00 |
| Sep 2020 | 21082000000.00 |
| Dec 2020 | 22475000000.00 |
| Apr 2021 | 22321000000.00 |
| Jul 2021 | 23312000000.00 |
| Oct 2021 | 23338000000.00 |
| Dec 2021 | 24804000000.00 |
| Apr 2022 | 23426000000.00 |
| Jul 2022 | 24020000000.00 |
| Oct 2022 | 19996000000.00 |
| Dec 2022 | 23706000000.00 |
| Apr 2023 | 20894000000.00 |
| Jul 2023 | 21519000000.00 |
| Oct 2023 | 21351000000.00 |
| Dec 2023 | 21395000000.00 |
| Mar 2024 | 21383000000.00 |
| Jun 2024 | 22447000000.00 |
| Sep 2024 | 22471000000.00 |
| Dec 2024 | 22520000000.00 |
| Mar 2025 | 21893000000.00 |
| Jun 2025 | 23743000000.00 |
| Sep 2025 | 23993000000.00 |
| Dec 2025 | 24564000000.00 |
| Mar 2026 | 24062000000.00 |
| Jun 2026 | 25310000000.00 |
Johnson & Johnson's annual revenue was $94.19 B in fiscal year 2025.
Johnson & Johnson's quarterly revenue was $21.89 B(Q1: Mar 2025), $23.74 B(Q2: Jun 2025), $23.99 B(Q3: Sep 2025), $24.56 B(Q4: Dec 2025) in fiscal year 2025.
Johnson & Johnson's annual revenue was $88.82 B in fiscal year 2024.
Johnson & Johnson's quarterly revenue was $21.38 B(Q1: Mar 2024), $22.45 B(Q2: Jun 2024), $22.47 B(Q3: Sep 2024), $22.52 B(Q4: Dec 2024) in fiscal year 2024.
Johnson & Johnson's annual revenue was $85.16 B in fiscal year 2023.
Johnson & Johnson's quarterly revenue was $20.89 B(Q1: Apr 2023), $21.52 B(Q2: Jul 2023), $21.35 B(Q3: Oct 2023), $21.40 B(Q4: Dec 2023) in fiscal year 2023.
Johnson & Johnson's annual revenue was $79.99 B in fiscal year 2022.
Johnson & Johnson's quarterly revenue was $23.43 B(Q1: Apr 2022), $24.02 B(Q2: Jul 2022), $20.00 B(Q3: Oct 2022), $23.71 B(Q4: Dec 2022) in fiscal year 2022.
Johnson & Johnson's annual revenue was $78.74 B in fiscal year 2021.
Johnson & Johnson's quarterly revenue was $22.32 B(Q1: Apr 2021), $23.31 B(Q2: Jul 2021), $23.34 B(Q3: Oct 2021), $24.80 B(Q4: Dec 2021) in fiscal year 2021.
Johnson & Johnson's annual revenue was $82.58 B in fiscal year 2020.
Johnson & Johnson's quarterly revenue was $20.69 B(Q1: Mar 2020), $18.34 B(Q2: Jun 2020), $21.08 B(Q3: Sep 2020), $22.48 B(Q4: Dec 2020) in fiscal year 2020.
Johnson & Johnson's annual revenue was $82.06 B in fiscal year 2019.
Johnson & Johnson's quarterly revenue was $20.02 B(Q1: Mar 2019), $20.56 B(Q2: Jun 2019), $20.73 B(Q3: Sep 2019), $20.75 B(Q4: Dec 2019) in fiscal year 2019.
Johnson & Johnson's annual revenue was $81.58 B in fiscal year 2018.
Johnson & Johnson's quarterly revenue was $20.01 B(Q1: Apr 2018), $20.83 B(Q2: Jul 2018), $20.35 B(Q3: Sep 2018), $20.39 B(Q4: Dec 2018) in fiscal year 2018.
Johnson & Johnson's annual revenue was $76.45 B in fiscal year 2017.
Johnson & Johnson's quarterly revenue was $17.77 B(Q1: Apr 2017), $18.84 B(Q2: Jul 2017), $19.65 B(Q3: Oct 2017), $20.20 B(Q4: Dec 2017) in fiscal year 2017.
Johnson & Johnson's annual revenue was $71.89 B in fiscal year 2016.
Johnson & Johnson's quarterly revenue was $17.48 B(Q1: Apr 2016), $18.48 B(Q2: Jul 2016), $17.82 B(Q3: Oct 2016), $18.11 B(Q4: Dec 2016) in fiscal year 2016.
| 2015 | 0 |
|---|---|
| 2016 | +2.59 |
| 2017 | +6.34 |
| 2018 | +6.71 |
| 2019 | +0.59 |
| 2020 | +0.64 |
| 2021 | -4.65 |
| 2022 | +1.59 |
| 2023 | +6.46 |
| 2024 | +4.30 |
| 2025 | +6.05 |
| Q1: Apr 16 | 0.62 |
|---|---|
| Q2: Jul 16 | 3.91 |
| Q3: Oct 16 | 4.20 |
| Q4: Dec 16 | 1.66 |
| Q1: Apr 17 | 1.62 |
| Q2: Jul 17 | 1.93 |
| Q3: Oct 17 | 10.27 |
| Q4: Dec 17 | 11.54 |
| Q1: Apr 18 | 12.63 |
| Q2: Jul 18 | 10.57 |
| Q3: Sep 18 | 3.55 |
| Q4: Dec 18 | 0.99 |
| Q1: Mar 19 | 0.06 |
| Q2: Jun 19 | -1.29 |
| Q3: Sep 19 | 1.87 |
| Q4: Dec 19 | 1.73 |
| Q1: Mar 20 | 3.35 |
| Q2: Jun 20 | -10.83 |
| Q3: Sep 20 | 1.70 |
| Q4: Dec 20 | 8.33 |
| Q1: Apr 21 | 7.88 |
| Q2: Jul 21 | 27.14 |
| Q3: Oct 21 | 10.70 |
| Q4: Dec 21 | 10.36 |
| Q1: Apr 22 | 4.95 |
| Q2: Jul 22 | 3.04 |
| Q3: Oct 22 | -14.32 |
| Q4: Dec 22 | -4.43 |
| Q1: Apr 23 | -10.81 |
| Q2: Jul 23 | -10.41 |
| Q3: Oct 23 | 6.78 |
| Q4: Dec 23 | -9.75 |
| Q1: Mar 24 | 2.34 |
| Q2: Jun 24 | 4.31 |
| Q3: Sep 24 | 5.25 |
| Q4: Dec 24 | 5.26 |
| Q1: Mar 25 | 2.39 |
| Q2: Jun 25 | 5.77 |
| Q3: Sep 25 | 6.77 |
| Q4: Dec 25 | 9.08 |
| Q1: Mar 26 | 9.91 |
| Q2: Jun 26 | 6.60 |
Johnson & Johnsonโs annual revenue increased +6.05% during fiscal year 2025 compared to 2024. It represents a growth of $5.37 B from $88.82 B (in 2024) to $94.19 B (in 2025).
Johnson & Johnsonโs annual revenue increased +4.30% during fiscal year 2024 compared to 2023. It represents a growth of $3.66 B from $85.16 B (in 2023) to $88.82 B (in 2024).
Johnson & Johnsonโs annual revenue increased +6.46% during fiscal year 2023 compared to 2022. It represents a growth of $5.17 B from $79.99 B (in 2022) to $85.16 B (in 2023).
Johnson & Johnsonโs annual revenue increased +1.59% during fiscal year 2022 compared to 2021. It represents a growth of $1.25 B from $78.74 B (in 2021) to $79.99 B (in 2022).
Johnson & Johnsonโs annual revenue decreased -4.65% during fiscal year 2021 compared to 2020. It represents a decline of $3.84 B from $82.58 B (in 2020) to $78.74 B (in 2021).
Johnson & Johnsonโs annual revenue increased +0.64% during fiscal year 2020 compared to 2019. It represents a growth of $525.00 M from $82.06 B (in 2019) to $82.58 B (in 2020).
Johnson & Johnsonโs annual revenue increased +0.59% during fiscal year 2019 compared to 2018. It represents a growth of $478.00 M from $81.58 B (in 2018) to $82.06 B (in 2019).
Johnson & Johnsonโs annual revenue increased +6.71% during fiscal year 2018 compared to 2017. It represents a growth of $5.13 B from $76.45 B (in 2017) to $81.58 B (in 2018).
Johnson & Johnsonโs annual revenue increased +6.34% during fiscal year 2017 compared to 2016. It represents a growth of $4.56 B from $71.89 B (in 2016) to $76.45 B (in 2017).
Johnson & Johnsonโs annual revenue increased +2.59% during fiscal year 2016 compared to 2015. It represents a growth of $1.82 B from $70.07 B (in 2015) to $71.89 B (in 2016).
| Period | Revenue | Year-over-Year Change |
|---|---|---|
|
Get instant access to data, Sign up for free 
FY 2025
|
$94.19 B |
$5.37 B
6.05%
|
| Q4: Dec 25 | $24.56 B |
$2.04 B
9.08%
|
| Q3: Sep 25 | $23.99 B |
$1.52 B
6.77%
|
| Q2: Jun 25 | $23.74 B |
$1.30 B
5.77%
|
| Q1: Mar 25 | $21.89 B |
$510.00 M
2.39%
|
|
Get instant access to data, Sign up for free
FY 2024
|
$88.82 B |
$3.66 B
4.3%
|
| Q4: Dec 24 | $22.52 B |
$1.13 B
5.26%
|
| Q3: Sep 24 | $22.47 B |
$1.12 B
5.25%
|
| Q2: Jun 24 | $22.45 B |
$928.00 M
4.31%
|
| Q1: Mar 24 | $21.38 B |
$489.00 M
2.34%
|
|
Get instant access to data, Sign up for free
FY 2023
|
$85.16 B |
$5.17 B
6.46%
|
| Q4: Dec 23 | $21.40 B |
-$2.31 B
9.75%
|
| Q3: Oct 23 | $21.35 B |
$1.36 B
6.78%
|
| Q2: Jul 23 | $21.52 B |
-$2.50 B
10.41%
|
| Q1: Apr 23 | $20.89 B |
-$2.53 B
10.81%
|
|
Get instant access to data, Sign up for free
FY 2022
|
$79.99 B |
$1.25 B
1.59%
|
| Q4: Dec 22 | $23.71 B |
-$1.10 B
4.43%
|
| Q3: Oct 22 | $20.00 B |
-$3.34 B
14.32%
|
| Q2: Jul 22 | $24.02 B |
$708.00 M
3.04%
|
| Q1: Apr 22 | $23.43 B |
$1.11 B
4.95%
|
|
Get instant access to data, Sign up for free
FY 2021
|
$78.74 B |
-$3.84 B
4.65%
|
| Q4: Dec 21 | $24.80 B |
$2.33 B
10.36%
|
| Q3: Oct 21 | $23.34 B |
$2.26 B
10.7%
|
| Q2: Jul 21 | $23.31 B |
$4.98 B
27.14%
|
| Q1: Apr 21 | $22.32 B |
$1.63 B
7.88%
|
|
Get instant access to data, Sign up for free
FY 2020
|
$82.58 B |
$525.00 M
0.64%
|
| Q4: Dec 20 | $22.48 B |
$1.73 B
8.33%
|
| Q3: Sep 20 | $21.08 B |
$353.00 M
1.7%
|
| Q2: Jun 20 | $18.34 B |
-$2.23 B
10.83%
|
| Q1: Mar 20 | $20.69 B |
$670.00 M
3.35%
|
|
Get instant access to data, Sign up for free
FY 2019
|
$82.06 B |
$478.00 M
0.59%
|
| Q4: Dec 19 | $20.75 B |
$353.00 M
1.73%
|
| Q3: Sep 19 | $20.73 B |
$381.00 M
1.87%
|
| Q2: Jun 19 | $20.56 B |
-$268.00 M
1.29%
|
| Q1: Mar 19 | $20.02 B |
$12.00 M
0.06%
|
|
Get instant access to data, Sign up for free
FY 2018
|
$81.58 B |
$5.13 B
6.71%
|
| Q4: Dec 18 | $20.39 B |
$199.00 M
0.99%
|
| Q3: Sep 18 | $20.35 B |
$698.00 M
3.55%
|
| Q2: Jul 18 | $20.83 B |
$1.99 B
10.57%
|
| Q1: Apr 18 | $20.01 B |
$2.24 B
12.63%
|
|
Get instant access to data, Sign up for free
FY 2017
|
$76.45 B |
$4.56 B
6.34%
|
| Q4: Dec 17 | $20.20 B |
$2.09 B
11.54%
|
| Q3: Oct 17 | $19.65 B |
$1.83 B
10.27%
|
| Q2: Jul 17 | $18.84 B |
$357.00 M
1.93%
|
| Q1: Apr 17 | $17.77 B |
$284.00 M
1.62%
|
|
Get instant access to data, Sign up for free
FY 2016
|
$71.89 B |
$1.82 B
2.59%
|
| Q4: Dec 16 | $18.11 B |
$295.00 M
1.66%
|
| Q3: Oct 16 | $17.82 B |
$718.00 M
4.2%
|
| Q2: Jul 16 | $18.48 B |
$695.00 M
3.91%
|
| Q1: Apr 16 | $17.48 B |
$108.00 M
0.62%
|
Agilent Technologies Revenue
Eli Lilly and Company Revenue
Stryker Corporation Revenue
AbbVie Revenue
Merck & Co. Revenue
Thermo Fisher Scientific Revenue
Abbott Laboratories Revenue
Danaher Corporation Revenue
Amgen Revenue
